Barnawi Ghassan, Alghamdi Fareeda S, Almuqati Amer S, Alamri Awadh
Dermatology, King Abdulaziz Medical City, Jeddah, SAU.
Plastic and Reconstructive Surgery, King Abdulaziz Medical City, Jeddah, SAU.
Cureus. 2022 Oct 4;14(10):e29914. doi: 10.7759/cureus.29914. eCollection 2022 Oct.
We discuss a case of a 63-year-old male who presented with generalized itchy papulonodular rash a few weeks after receiving a vaccination against SARS-CoV-2. The patient had a negative medical history for atopic dermatitis and other pruritic skin conditions, and clinical presentation was consistent with prurigo nodularis, which was confirmed later by tissue biopsy and microscopic analysis. The pathophysiology of this skin condition is thought to be due to an overlap between the immune and nervous systems. Due to the hypothesized involvement of the immune system in this disease, it. is presumed that the patient had a dysregulated immune response caused by his recent SARS-CoV-2 vaccination.
我们讨论一例63岁男性病例,该患者在接种抗SARS-CoV-2疫苗几周后出现全身性瘙痒性丘疹结节性皮疹。患者既往无特应性皮炎和其他瘙痒性皮肤病病史,临床表现符合结节性痒疹,后来经组织活检和显微镜分析得以证实。这种皮肤疾病的病理生理学被认为是由于免疫系统和神经系统之间的重叠。由于推测免疫系统参与了这种疾病,据推测患者最近接种SARS-CoV-2疫苗导致了免疫反应失调。